This company has shut down. Blue Note Therapeutics is no longer operating — its last tracked round was a Series A in 2021.
Explore the Startup GraveyardBlue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise.
Blue Note Therapeutics has raised $5.2M in total funding. The most recent round was Series A. The last funding was announced in September 2021.
Blue Note Therapeutics's investors include Alumni Ventures, Memorial Sloan - Kettering Cancer Center, Jazz Venture Partners, Green D Ventures, Summer VC.
Blue Note Therapeutics is headquartered in San Francisco, United States.
Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise.
Blue Note Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Blue Note Therapeutics — Funding & Investors." VCBacked, September 9, 2021, https://www.vcbacked.co/company/blue-note-therapeutics. Accessed August 13, 2026.
VCBacked. (2021). Blue Note Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/blue-note-therapeutics
{{cite web |title=Blue Note Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/blue-note-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated